Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contact Lenses, Hydrophilic | 18 | 2023 | 78 | 7.950 |
Why?
|
| Myopia | 13 | 2023 | 114 | 5.970 |
Why?
|
| Astigmatism | 6 | 2022 | 35 | 3.550 |
Why?
|
| Contact Lenses | 5 | 2022 | 71 | 2.190 |
Why?
|
| Humans | 35 | 2024 | 4936 | 1.810 |
Why?
|
| Orthokeratologic Procedures | 5 | 2023 | 9 | 1.780 |
Why?
|
| Atropine | 2 | 2023 | 9 | 1.510 |
Why?
|
| Adult | 17 | 2023 | 1567 | 1.450 |
Why?
|
| Visual Acuity | 6 | 2022 | 179 | 1.220 |
Why?
|
| Tears | 5 | 2022 | 21 | 1.130 |
Why?
|
| Young Adult | 10 | 2022 | 787 | 1.040 |
Why?
|
| Refraction, Ocular | 8 | 2023 | 127 | 1.030 |
Why?
|
| Lens, Crystalline | 4 | 2024 | 34 | 1.030 |
Why?
|
| Keratitis | 2 | 2023 | 3 | 0.950 |
Why?
|
| Eyeglasses | 2 | 2022 | 30 | 0.920 |
Why?
|
| Eye Diseases | 2 | 2022 | 16 | 0.900 |
Why?
|
| Child | 8 | 2023 | 627 | 0.860 |
Why?
|
| Quality of Life | 2 | 2022 | 87 | 0.860 |
Why?
|
| Lenses, Intraocular | 2 | 2021 | 9 | 0.830 |
Why?
|
| Corneal Diseases | 1 | 2023 | 10 | 0.770 |
Why?
|
| Corneal Ulcer | 2 | 2021 | 4 | 0.750 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 24 | 0.750 |
Why?
|
| Glucose | 1 | 2022 | 13 | 0.740 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 7 | 0.730 |
Why?
|
| Insulin | 1 | 2022 | 29 | 0.730 |
Why?
|
| Parents | 1 | 2022 | 58 | 0.710 |
Why?
|
| Surveys and Questionnaires | 6 | 2022 | 258 | 0.710 |
Why?
|
| Hyperemia | 1 | 2021 | 3 | 0.690 |
Why?
|
| Male | 11 | 2023 | 2491 | 0.670 |
Why?
|
| Female | 11 | 2023 | 2523 | 0.670 |
Why?
|
| Accommodation, Ocular | 2 | 2024 | 36 | 0.660 |
Why?
|
| Computers | 1 | 2020 | 16 | 0.640 |
Why?
|
| Disease Management | 1 | 2020 | 4 | 0.640 |
Why?
|
| Dry Eye Syndromes | 1 | 2020 | 12 | 0.620 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 10 | 0.620 |
Why?
|
| Adolescent | 6 | 2022 | 758 | 0.610 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 32 | 0.610 |
Why?
|
| Cornea | 4 | 2021 | 140 | 0.580 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 2 | 0.580 |
Why?
|
| Cytokines | 1 | 2018 | 37 | 0.570 |
Why?
|
| Microbiota | 1 | 2018 | 14 | 0.560 |
Why?
|
| Risk Factors | 7 | 2022 | 159 | 0.520 |
Why?
|
| Conjunctiva | 3 | 2022 | 13 | 0.500 |
Why?
|
| Case-Control Studies | 3 | 2022 | 81 | 0.480 |
Why?
|
| Aging | 2 | 2024 | 109 | 0.470 |
Why?
|
| Refractive Errors | 1 | 2016 | 58 | 0.440 |
Why?
|
| Pilot Projects | 4 | 2022 | 98 | 0.400 |
Why?
|
| Cross-Over Studies | 3 | 2022 | 31 | 0.390 |
Why?
|
| Ophthalmic Solutions | 2 | 2023 | 7 | 0.380 |
Why?
|
| Disease Progression | 3 | 2022 | 59 | 0.380 |
Why?
|
| Retrospective Studies | 3 | 2023 | 341 | 0.370 |
Why?
|
| Prospective Studies | 2 | 2023 | 111 | 0.360 |
Why?
|
| Prediabetic State | 2 | 2020 | 9 | 0.320 |
Why?
|
| Contrast Sensitivity | 2 | 2021 | 64 | 0.310 |
Why?
|
| Retina | 2 | 2022 | 130 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 39 | 0.310 |
Why?
|
| Disposable Equipment | 2 | 2022 | 2 | 0.240 |
Why?
|
| Incidence | 2 | 2023 | 30 | 0.240 |
Why?
|
| Proteome | 2 | 2022 | 7 | 0.230 |
Why?
|
| Proteomics | 2 | 2022 | 19 | 0.230 |
Why?
|
| Blood Glucose | 2 | 2022 | 29 | 0.230 |
Why?
|
| Presbyopia | 1 | 2024 | 5 | 0.210 |
Why?
|
| Vision Tests | 2 | 2021 | 50 | 0.210 |
Why?
|
| Drug Compounding | 1 | 2023 | 3 | 0.200 |
Why?
|
| United States | 2 | 2022 | 495 | 0.190 |
Why?
|
| Students, Health Occupations | 1 | 2022 | 1 | 0.190 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 5 | 0.190 |
Why?
|
| Medicine | 1 | 2022 | 4 | 0.190 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 2 | 0.190 |
Why?
|
| Glucose Tolerance Test | 1 | 2022 | 3 | 0.190 |
Why?
|
| Pharmacy | 1 | 2022 | 16 | 0.180 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 2021 | 1 | 0.170 |
Why?
|
| Software | 1 | 2021 | 57 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2020 | 14 | 0.170 |
Why?
|
| Corneal Topography | 1 | 2021 | 37 | 0.170 |
Why?
|
| Ophthalmic Nerve | 1 | 2020 | 2 | 0.160 |
Why?
|
| Axial Length, Eye | 2 | 2023 | 25 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2020 | 32 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2020 | 47 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 1 | 0.150 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2019 | 2 | 0.150 |
Why?
|
| Interleukin-8 | 1 | 2019 | 4 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2019 | 7 | 0.150 |
Why?
|
| Reading | 1 | 2020 | 74 | 0.150 |
Why?
|
| Middle Aged | 3 | 2020 | 967 | 0.150 |
Why?
|
| Epithelium, Corneal | 1 | 2019 | 13 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 19 | 0.150 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2018 | 1 | 0.150 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 4 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2018 | 9 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 7 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 17 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 18 | 0.140 |
Why?
|
| Genotype | 1 | 2018 | 40 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 36 | 0.140 |
Why?
|
| Eye Proteins | 1 | 2018 | 36 | 0.140 |
Why?
|
| Microscopy, Acoustic | 1 | 2016 | 5 | 0.120 |
Why?
|
| Corneal Pachymetry | 1 | 2016 | 7 | 0.120 |
Why?
|
| Interferometry | 1 | 2016 | 6 | 0.120 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 12 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 197 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 217 | 0.100 |
Why?
|
| Cell Count | 2 | 2020 | 34 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 49 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 269 | 0.070 |
Why?
|
| Aged | 2 | 2020 | 703 | 0.060 |
Why?
|
| Attitude | 1 | 2022 | 14 | 0.050 |
Why?
|
| Health Occupations | 1 | 2022 | 1 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 6 | 0.050 |
Why?
|
| Self Report | 1 | 2022 | 67 | 0.050 |
Why?
|
| Electroretinography | 1 | 2020 | 57 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 55 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 94 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 6 | 0.040 |
Why?
|
| Methacrylates | 1 | 2019 | 4 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 21 | 0.040 |
Why?
|
| Silicones | 1 | 2019 | 11 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 9 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2019 | 2 | 0.040 |
Why?
|
| Hydrogels | 1 | 2019 | 14 | 0.040 |
Why?
|
| Informed Consent | 1 | 2019 | 1 | 0.040 |
Why?
|
| Off-Label Use | 1 | 2019 | 1 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Internationality | 1 | 2019 | 6 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 65 | 0.040 |
Why?
|
| Protein Binding | 1 | 2019 | 115 | 0.040 |
Why?
|
| Habits | 1 | 2017 | 2 | 0.030 |
Why?
|
| Consumer Behavior | 1 | 2017 | 2 | 0.030 |
Why?
|